-

ABOUT US

Honor


  The company currently has 28 authorized invention patents,and more than 170 invention patents have been submitted for application and are in various stages of examination;A number of other patents are pending.

  Innovative Drug development:

  The research and development of 16 innovative drugs for cardio-cerebrovascular,respiratory,renal and antifungal systems has been carried out.

  1 project is in phase II clinical development;Three projects are in phase I clinical development;Five projects are being prepared for IND.

  More than 170 invention patents have been applied for or authorized,including 36 PCT patents;

  Generic Drug development:

  13 projects under research;

  Obtained 9 production approvals and 7 new drug certificates;

  176 registered trademarks.

 

 

1